Pro Medicus Limited (PMCUF) Stock Forecast & Price Target

Compare

31 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PMCUF Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Pro

Medicus Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PMCUF Stock 12 Month Forecast

Average Price Target

$220.85

▲(46.40% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Pro Medicus Limited in the last 3 months. The average price target is $220.85 with a high forecast of $233.55 and a low forecast of $193.51. The average price target represents a 46.40% change from the last price of $150.85.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"123":"$123","234":"$234","150.75":"$150.8","178.5":"$178.5","206.25":"$206.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":233.54975,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$233.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":220.85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$220.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":193.51265,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$193.51</span>\n  </div></div>","useHTML":true}}],"tickPositions":[123,150.75,178.5,206.25,234],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180,184.11921153846154,188.23842307692308,192.3576346153846,196.47684615384614,200.59605769230768,204.71526923076922,208.83448076923077,212.9536923076923,217.07290384615385,221.19211538461536,225.3113269230769,229.43053846153845,{"y":233.54975,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180,183.1423076923077,186.2846153846154,189.42692307692306,192.56923076923076,195.71153846153845,198.85384615384615,201.99615384615385,205.13846153846154,208.28076923076924,211.4230769230769,214.5653846153846,217.7076923076923,{"y":220.85,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,180,181.0394346153846,182.07886923076924,183.11830384615385,184.15773846153846,185.1971730769231,186.2366076923077,187.2760423076923,188.31547692307691,189.35491153846155,190.39434615384616,191.43378076923076,192.4732153846154,{"y":193.51265,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":129.86,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":159.31,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":154.97,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.62,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.33,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.81,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":202.17,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.55,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.88,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$233.55

Average Price Target$220.85

Lowest Price Target$193.51

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Chris Boulus

Morgan Stanley

$233.55

Buy

54.82%

Upside

Reiterated

12/08/25

Morgan Stanley Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)

Madeleine Williams

Canaccord Genuity

$233.55

Buy

54.82%

Upside

Reiterated

12/08/25

Canaccord Genuity Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF)

Laura Sutcliffe

Citi

$233.55

Buy

54.82%

Upside

Reiterated

11/25/25

Citi Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)

Iain Wilkie

Morgans

$193.51

Buy

28.28%

Upside

Upgraded

11/16/25

Positive Report for Pro Medicus Limited (PMCUF) from Morgans

John Hester

Bell Potter

$213.53

Buy

41.55%

Upside

Upgraded

11/11/25

Pro Medicus Limited (PMCUF) was upgraded to a Buy Rating at Bell Potter

Sinclair Currie

MA Financial Group

$228.2→$217.41

Hold

44.13%

Upside

Reiterated

09/16/25

MA Financial Group Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$203.52

Hold

34.92%

Upside

Reiterated

08/19/25

Ord Minnett Remains a Hold on Pro Medicus Limited (PMCUF)

Wei Sim

Jefferies

$200.19

Hold

32.71%

Upside

Reiterated

08/15/25

Jefferies Sticks to Its Hold Rating for Pro Medicus Limited (PMCUF)

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$214.6

Hold

42.26%

Upside

Reiterated

08/15/25

Macquarie Remains a Hold on Pro Medicus Limited (PMCUF)

Garry Sherriff

RBC Capital

$233.55→$226.88

Hold

50.40%

Upside

Reiterated

08/14/25

RBC Capital Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)

David Low

J.P. Morgan

$200.19

Hold

32.71%

Upside

Reiterated

08/14/25

J.P. Morgan Remains a Hold on Pro Medicus Limited (PMCUF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$203.52

Hold

34.92%

Upside

Reiterated

07/04/25

Ord Minnett Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)

Annabel Li

Goldman Sachs

$206.19→$206.86

Buy

37.13%

Upside

Reiterated

06/27/25

Pro Medicus Limited (PMCUF) Receives a Buy from Goldman Sachs

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$172.49

Hold

14.35%

Upside

Reiterated

02/14/25

Andrew Paine

CLSA

$186.84→$205.52

Buy

36.24%

Upside

Reiterated

02/14/25

Pro Medicus Ltd. (PME:AU) (PMCUF) PT Raised to AUD308 at CLSACLSA analyst Andrew Paine raised the price target on Pro Medicus Ltd. (PME:AU) (OTC: PMCUF) to AUD308.00 (from AUD280.00) while maintaining a Outperform (2) rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Chris Boulus

Morgan Stanley

$233.55

Buy

54.82%

Upside

Reiterated

12/08/25

Morgan Stanley Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)

Madeleine Williams

Canaccord Genuity

$233.55

Buy

54.82%

Upside

Reiterated

12/08/25

Canaccord Genuity Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF)

Laura Sutcliffe

Citi

$233.55

Buy

54.82%

Upside

Reiterated

11/25/25

Citi Sticks to Their Buy Rating for Pro Medicus Limited (PMCUF)

Iain Wilkie

Morgans

$193.51

Buy

28.28%

Upside

Upgraded

11/16/25

Positive Report for Pro Medicus Limited (PMCUF) from Morgans

John Hester

Bell Potter

$213.53

Buy

41.55%

Upside

Upgraded

11/11/25

Pro Medicus Limited (PMCUF) was upgraded to a Buy Rating at Bell Potter

Sinclair Currie

MA Financial Group

$228.2→$217.41

Hold

44.13%

Upside

Reiterated

09/16/25

MA Financial Group Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$203.52

Hold

34.92%

Upside

Reiterated

08/19/25

Ord Minnett Remains a Hold on Pro Medicus Limited (PMCUF)

Wei Sim

Jefferies

$200.19

Hold

32.71%

Upside

Reiterated

08/15/25

Jefferies Sticks to Its Hold Rating for Pro Medicus Limited (PMCUF)

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$214.6

Hold

42.26%

Upside

Reiterated

08/15/25

Macquarie Remains a Hold on Pro Medicus Limited (PMCUF)

Garry Sherriff

RBC Capital

$233.55→$226.88

Hold

50.40%

Upside

Reiterated

08/14/25

RBC Capital Keeps Their Hold Rating on Pro Medicus Limited (PMCUF)

David Low

J.P. Morgan

$200.19

Hold

32.71%

Upside

Reiterated

08/14/25

J.P. Morgan Remains a Hold on Pro Medicus Limited (PMCUF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

$203.52

Hold

34.92%

Upside

Reiterated

07/04/25

Ord Minnett Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)

Annabel Li

Goldman Sachs

$206.19→$206.86

Buy

37.13%

Upside

Reiterated

06/27/25

Pro Medicus Limited (PMCUF) Receives a Buy from Goldman Sachs

Unknown Analyst

Macquarie

Not Ranked

Macquarie

$172.49

Hold

14.35%

Upside

Reiterated

02/14/25

Andrew Paine

CLSA

$186.84→$205.52

Buy

36.24%

Upside

Reiterated

02/14/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pro Medicus Limited

1 Month

xxx

Success Rate

8/9 ratings generated profit

Average Return

+8.98%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 88.89% of your transactions generating a profit, with an average return of +8.98% per trade.

3 Months

xxx

Success Rate

7/9 ratings generated profit

Average Return

+18.81%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +18.81% per trade.

1 Year

Iain WilkieMorgans

Success Rate

11/14 ratings generated profit

Average Return

+55.12%

upgraded a buy rating 26 days ago

Copying Iain Wilkie's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +55.12% per trade.

2 Years

xxx

Success Rate

12/14 ratings generated profit

Average Return

+70.63%

upgraded a xxx

rating 26 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +70.63% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PMCUF Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PMCUF has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PMCUF average Analyst price target in the past 3 months is 220.85.

Each month's total comprises the sum of three months' worth of ratings.

PMCUF Financial Forecast

PMCUF Earnings Forecast

Next quarter’s earnings estimate for PMCUF is $0.45 with a range of $0.45 to $0.45. The previous quarter’s EPS was $0.40. PMCUF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.

PMCUF Sales Forecast

Next quarter’s sales forecast for PMCUF is $87.48M with a range of $87.41M to $87.55M. The previous quarter’s sales results were $77.26M. PMCUF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PMCUF has Performed in-line its overall industry.

PMCUF Stock Forecast FAQ

What is PMCUF’s average 12-month price target, according to analysts?

Based on analyst ratings, Pro Medicus Limited’s 12-month average price target is 220.85.

What is PMCUF’s upside potential, based on the analysts’ average price target?

Pro Medicus Limited has 46.40% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PMCUF a Buy, Sell or Hold?

Pro Medicus Limited has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Pro Medicus Limited’s price target?

The average price target for Pro Medicus Limited is 220.85. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $233.55 ,the lowest forecast is $193.51. The average price target represents 46.40% Increase from the current price of $150.85.

What do analysts say about Pro Medicus Limited?

Pro Medicus Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of PMCUF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Pro Medicus Limited (PMCUF) Stock Forecast & Price Target

PMCUF Analyst Ratings

PMCUF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Pro Medicus Limited

PMCUF Analyst Recommendation Trends

PMCUF Financial Forecast

PMCUF Earnings Forecast

PMCUF Sales Forecast

PMCUF Stock Forecast FAQ

Detailed List of Analyst Forecasts